Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273845 · ClinicalTrials.gov registry record · Phase 2
Reducing Barriers to Drug Abuse Treatment Services
A Phase 2 study, sponsored by Wright State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 678
- Enrollment target
NCT00273845: Completed Phase 2 study, sponsored by Wright State University.
NCT00273845 is a Phase 2 study that has completed, run by Wright State University. The registered enrollment target is 678 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (410% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00273845, a Phase 2 study, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 678 participants
- Enrollment target
Study Summary
The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engagement" represents a more comprehensive conceptualization of "treatment retention" and includes measures of the clinical and ancillary services actually received by the client over time; as such, client engagement focuses on the intensity and duration of treatment participation. This study will enhance the CIU concept by conducting a controlled trial, using a three-armed research design, of interventions designed to enhance treatment linkage and treatment engagement. These interventions - a Motivational Intervention and Strengths-Based Case Management - are science-based and have demonstrated efficacy in moving drug abusers towards treatment and supporting treatment engagement.
Interventions
- BEHAVIORAL Motivational interviewing
- BEHAVIORAL Strengths-Based Case Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2003-05 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
What the finished NCT00273845 record still lists
NCT00273845 is an interventional study that assigns participants to a tested intervention. The registered 678 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (410% higher).
The record links to 0 conditions, and to 2 interventions - of which Motivational interviewing is the first listed.
NCT00273845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00273845 about?
NCT00273845 is a clinical study titled "Reducing Barriers to Drug Abuse Treatment Services". The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engage...
What is the current status of trial NCT00273845?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 678 participants. The study started on 2003-05. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00273845?
The interventions under investigation include: Motivational interviewing (BEHAVIORAL), Strengths-Based Case Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00273845?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00273845's enrollment target sits among peer trials
678 48th of 2000 higher than 1,953 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05372484 · 678 participants · NA
Rice Technologies for Cervical Cancer Screening and Diagnosis
- NCT06436924 · 678 participants
Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia